Open access · CC-BY
via OpenAlex
Senolytic treatment with dasatinib and quercetin does not improve overall influenza responses in aged mice
Blake L. Torrance, Andreia N. Cadar, Dominique E. Martin, Hunter A. Panier, Erica C. Lorenzo, Jenna M. Bartley, Ming Xu, Laura Haynes
Frontiers in Aging · 2023 · ▲ 18 citations
Abstract
Age is the greatest risk factor for adverse outcomes following influenza (flu) infection. The increased burden of senescent cells with age has been identified as a root cause in many diseases of aging and targeting these cells with drugs termed senolytics(definition) has shown promise in alleviating many age-related declines across organ systems. However, there is little known whether targeting these cells will improve age-related deficits in the immune system. Here, we utilized a well characterized senolytic treatment with a combination of dasatinib and quercetin (D + Q) to clear aged (18-20 months) mice of senescent cells prior to a flu infection. We comprehensively profiled immune responses during the primary infection as well as development of immune memory and protection following pathogen reencounter. Senolytic treatment did not improve any aspects of the immune response that were assayed for including: weight loss, viral load, CD8 T-cell infiltration, antibody production, memory T cell development, or recall ability. These results indicate that D + Q may not be an appropriate senolytic to improve aged immune responses to flu infection.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fragi.2023.1212750
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Torrance, B.L., Cadar, A.N., Martin, D.E., Panier, H.A., Lorenzo, E.C., Bartley, J.M., Xu, M., & Haynes, L. (2023). Senolytic treatment with dasatinib and quercetin does not improve overall influenza responses in aged mice. <em>Frontiers in Aging</em>. https://doi.org/10.3389/fragi.2023.1212750
Vancouver
Torrance BL, Cadar AN, Martin DE, Panier HA, Lorenzo EC, Bartley JM, et al. Senolytic treatment with dasatinib and quercetin does not improve overall influenza responses in aged mice. Frontiers in Aging. 2023. doi:10.3389/fragi.2023.1212750.
BibTeX
@article{blake2023Senoly,
title = {Senolytic treatment with dasatinib and quercetin does not improve overall influenza responses in aged mice},
author = {Blake L. Torrance and Andreia N. Cadar and Dominique E. Martin and Hunter A. Panier and Erica C. Lorenzo and Jenna M. Bartley and Ming Xu and Laura Haynes},
journal = {Frontiers in Aging},
year = {2023},
doi = {10.3389/fragi.2023.1212750},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2025
Open access · CC-BY
Senolytic Treatment With Dasatinib and Quercetin Reshapes Influenza‐Specific CD8 T Cell Responses During Infection in Aged, Vaccinated Mice
Frontiers in Aging 2026
Open access · CC-BY
The effect of metformin treatment during primary influenza infection on heterologous challenge in young and aged mice
Frontiers in aging 2026
Open access · OA
The effect of metformin treatment during primary influenza infection on heterologous challenge in young and aged mice.
Aging Cell 2025
Open access · CC-BY
Senolytic treatment attenuates immune cell infiltration without improving IAV outcomes in aged mice
Aging Cell 2021
Open access · CC-BY
Senescence‐induced changes in CD4 T cell differentiation can be alleviated by treatment with senolytics
Aging cell 2026
Citation only